Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 01, 2021
Source ID
10.1016/j.immuni.2021.01.017

Entities

People

  • Benjamin R tenOever
  • Daisy A Hoagland
  • Daniel Blanco-melo
  • David Sachs
  • Ilona Golynker
  • Jean K Lim
  • Justin Frere
  • Knarik Arkun
  • Kohei Oishi
  • Maryline Panis
  • Rasmus Møller
  • Shu Horiuchi
  • Skyler A. Uhl

Organizations

  • Defense Advanced Research Projects Agency